Ball to benefit humane center
Spotted: Shamrock Shuffle
'09-'10 Miami hockey season photos
Blogs & Message Boards More...
- Here's the deal: Bargains in Dayton: Free educational event for uninsured Friday
- Flyer Connection: University of Dayton sports: Lutz fired as coach at Charlotte
- Leadbelly Blog: Some new pizza I really like
- Arts and Entertainment: Area comedian not 'Next Big Comic'
- A Matter of Opinion: Editorial: Lehner move could help patients save
|
Solostar Injection Pen Approved for Diabetes THURSDAY, Feb. 26 (HealthDay News) -- Sanofi-Aventis's Apidra (insulin glulisine) Solostar injection pen has been approved to treat diabetes, the company said Thursday in a news release. The disposable pen with rapid-acting insulin was approved for adults with type 2 diabetes and for children four years and older with type 1 diabetes. The device requires lower injection force than competing products, the drug maker said. More information The FDA has additional information about Apidra, a drug first approved in 2004.
|
||
|
Copyright © 2009 ScoutNews, LLC. All rights reserved. |
||
|
|
||
 |
|
|